June 19th, 2025 - Study Cases

Spotlight On: The 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) Mouse Model for Biliary Fibrosis

Have a liver-targeted antifibrotic or anti-inflammatory candidate? Discover how we stress-test anti-fibrotics in vivo

At Dev4All, we’ve validated the xenobiotic-induced 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) model in detail and we’d be happy to share our insights.

✅ Defined timeline: 4–8 weeks
✅ Validated biomarkers & histopathology
✅ Customizable protocols to match your indication

📩 Want to receive our detailed study design or endpoint sheet ?

Interested in our preclinical models or meeting us at an event? Contact Daniel Sanchez Lopez or Céline Martin.

To learn more about the paper, click on the image to view the full post




Reach our Experts